$34.60
0.010.03%
At close: Aug 4, 5:00 PM EST
$35.00
0.411.19%
Pre-Market: 4:09 AM EST
Roivant Sciences (ROIV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.36 | $-0.34 | $-0.32 |
| Actual | — | $-0.27 | $-0.24 | $-0.28 |
| Surprise | — | +23.9% | +29.4% | +12.5% |
| Revenue | ||||
| Estimate | $2.3M | $3.7M | $6.1M | $6.7M |
| Actual | — | $2.5M | $2.0M | $1.6M |
| Surprise | — | -31.6% | -67.4% | -76.5% |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.41 | $-0.42 | $-0.49 |
| Revenue | |||
| Consensus | $3.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | May 20, 2026 | $-0.27 | $-0.36 | 23.9 % |
| Q3 | Feb 6, 2026 | $-0.24 | $-0.34 | 29.4 % |
| Q2 | Nov 10, 2025 | $-0.28 | $-0.32 | 12.5 % |
| Q1 | Aug 11, 2025 | $-0.25 | $-0.26 | 3.85 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | May 20, 2026 | $2.52M | $3.68M | -31.6 % |
| Q3 | Feb 6, 2026 | $2.00M | $6.13M | -67.4 % |
| Q2 | Nov 10, 2025 | $1.57M | $6.68M | -76.5 % |
| Q1 | Aug 11, 2025 | $2.17M | $7.19M | -69.8 % |